1. Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment.
    Jaehong Kim et al, 2016, Mediators Inflamm CrossRef
  2. NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8+ T cells for tumor promotion
    Liwen Li et al, 2018, OncoImmunology CrossRef
  3. Correlation of IDH1 and B7H3 expression with prognosis of CRC patients.
    Jingyi Wu et al, 2018, Eur J Surg Oncol CrossRef
  4. Soluble immune checkpoints in cancer: production, function and biological significance
    Daqian Gu et al, 2018, j. immunotherapy cancer CrossRef
  5. The novel non-immunological role and underlying mechanisms of B7-H3 in tumorigenesis
    Xiangqi Zhou et al, 2019, J Cell Physiol CrossRef
  6. Recent advances of immunotherapy in lung cancer: anti-programmed cell death-1/programmed death ligand-1 antibodies
    Lu-Lu Yang et al, 2014, Lung Cancer Management CrossRef
  7. Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis
    WEI DAI et al, 2014 CrossRef
  8. Macrophages, Neutrophils, and Cancer: A Double Edged Sword
    Alberto Mantovani, 2014, New Journal of Science CrossRef
  9. Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression
    FU-BIAO KANG et al, 2015 CrossRef
  10. Inhibitory receptors as targets for cancer immunotherapy
    Meghan E. Turnis et al, 2015, Eur. J. Immunol. CrossRef
  11. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer
    Pei Zhang et al, 2015 CrossRef
  12. B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer
    FEN LIU et al, 2015 CrossRef
  13. Differential expression of 2IgB7-H3 and 4IgB7-H3 in cancer cell lines and glioma tissues
    ZHENXIN WANG et al, 2015 CrossRef
  14. miR-130a regulates macrophage polarization and is associated with non-small cell lung cancer
    LIN LIN et al, 2015 CrossRef
  15. B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway
    Bo Jiang et al, 2016, Tumor Biol. CrossRef
  16. Prognostic significance of CD276 in non-small cell lung cancer
    Changgong Zhang et al, 2019 CrossRef
  17. Involvement of soluble B7‑H3 in combination with the serum inflammatory cytokines interleukin‑17, ‑8 and ‑6 in the diagnosis of hepatocellular carcinoma
    Fenghuang Xu et al, 2017, Oncol Lett CrossRef
  18. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer
    Xiang Yang et al, 2020, Technol Cancer Res Treat CrossRef
  19. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
    Zhe Ge et al, 2020, Front Oncol CrossRef
  20. Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation
    Jingjiao Zhou et al, 2017, Cancer Immunol Res CrossRef
  21. High expression of cluster of differentiation 276 indicates poor prognosis in glioma
    Linchen Li et al, 2021, Clin Med Insights Oncol CrossRef
  22. B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia
    Shuangshuang Fan et al, 2023, Eur J Med Res CrossRef
  23. From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer
    Yibin Zhou et al, 2024, Front. Immunol. CrossRef